| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 48 |
| 1 | ASPIRIN | 45 |
| 2 | ASPIRIN 325 MG | 44 |
| 3 | ASPIRIN 81 MG | 44 |
| 4 | PREDNISONE | 40 |
| 5 | TACROLIMUS | 32 |
| 6 | ADALIMUMAB | 30 |
| 7 | PREDNISOLONE | 30 |
| 8 | PREDNISOLONE ORAL | 30 |
| 9 | PREDNISOLONE ORAL SOLUTION | 30 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADENINE | 1 | 0.0204 |
| 1 | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | 1 | 0.0115 |
| 2 | TRIFAROTENE | 1 | 0.0055 |
| 3 | PEGFILGRASTIM | 48 | 0.0040 |
| 4 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 5 | PORFIMER SODIUM | 1 | 0.0029 |
| 6 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 7 | PEGFILGRASTIM-BMEZ | 1 | 0.0016 |
| 8 | GINKGO BILOBA | 2 | 0.0014 |
| 9 | ATENOLOL AND CHLORTHALIDONE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 106 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 77 |
| 2 | Leukocyte Growth Factor [EPC] | 50 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 46 |
| 4 | Platinum-based Drug [EPC] | 35 |
| 5 | Benzodiazepine [EPC] | 30 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 30 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 30 |
| 8 | Alkylating Drug [EPC] | 29 |
| 9 | Microtubule Inhibitor [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 1 | 0.0011 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 4 | 0.0008 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 3 | Leukocyte Growth Factor [EPC] | 50 | 0.0004 |
| 4 | Vitamin K [EPC] | 3 | 0.0003 |
| 5 | Calcitonin [EPC] | 1 | 0.0003 |
| 6 | Rifamycin Antimycobacterial [EPC] | 1 | 0.0003 |
| 7 | Allylamine Antifungal [EPC] | 2 | 0.0003 |
| 8 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 9 | Anti-coagulant [EPC] | 1 | 0.0003 |